Alzheimer's Society responds to Bruce Willis’ frontotemporal dementia diagnosis

Friday 17 February 2023

Alzheimer's Society CEO Kate Lee responds to news that Hollywood actor Bruce Willis has been diagnosed with frontotemporal dementia.

Alzheimer's Society has responded to news that Hollywood actor Bruce Willis has been diagnosed with frontotemporal dementia (FTD).

The actor's family released a statement announcing the 67-year-old's diagnosis, following his retirement last year due to aphasia, which is when a person has difficulty with speech or language.

Kate Lee, Alzheimer's Society CEO, said: “We're sending our thoughts to Bruce Willis and his family following their announcement that Bruce is living with frontotemporal dementia.

"Speaking publicly about his diagnosis will help so much to shine further light on the condition, for which we are hugely thankful. For those who have been affected by this news, support is available on the Alzheimer's Society website."

Frontotemporal dementia is a less common type of dementia and is mostly diagnosed between the ages of 45 and 65, although it can also affect people younger or older than this.

If you are worried about frontotemporal dementia or how to support someone with FTD, call our support line on 0333 150 3456.

Find out more about frontotemporal dementia

Learn more about frontotemporal dementia, including symptoms and how to find support.

Paying for dementia care in Northern Ireland

Paying for care can be worrying to think about. With the right information and support, you can better understand your options and make the right decisions for you. Read about the different ways to pay for care in Northern Ireland.

Advice

What is the difference between dementia and Alzheimer’s disease?

An older woman and man sitting at a table outside having a cup of tea

Advice

13 November 2024

Angela Rippon CBE backs charity’s call to make dementia training mandatory

Alzheimer's Society says it’s alarming that nearly two thirds of care workers have not received any dementia training, and a long-term social care workforce strategy is needed.

Why dementia training for care workers matters and how to deliver it

Alzheimer’s Society’s latest report demonstrates the importance of high-quality, mandatory dementia training for the social care workforce

Blood Biomarker Challenge to 'revolutionise' dementia diagnosis

Alzheimer’s Society is continuing work on the Blood Biomarker Challenge, a project that could bring dementia blood tests to the NHS within five years.

Advice